P

Active Director Director DIN 09363077
DIN 09363077 First appointment Oct 2021 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Priyanka

Data last updated:

Priyanka is a Director at Ulcone Pharmaceuticals Private Limited (since 2021). The company operates in Food And Beverages. Ulcone Pharmaceuticals Private Limited reported revenue of ₹8.8 Lakh (FY 2025).

DIN 09363077
Primary Designation Director
Industry Food And Beverages
First Appointment 18 Oct 2021
Oldest Company Age 5 yrs
Largest company Ulcone Pharmaceuticals Private Limited · ₹8.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Oct 20212021₹8.8 Lakh (FY 2025)Active

Board colleagues of Priyanka

NameDINCompanyDesignation
Tulika Srivastava09363078Ulcone Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ulcone Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka

Priyanka currently holds 1 directorship: Ulcone Pharmaceuticals Private Limited (Director, since 18 Oct 2021, revenue ₹8.8 Lakh (FY 2025)).

Priyanka was first appointed on 18 Oct 2021 as Director at Ulcone Pharmaceuticals Private Limited.

The current boards of Priyanka's companies include Tulika Srivastava (Ulcone Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available